Fulcrum Therapeutics
FULC
#8269
Rank
S$0.21 B
Marketcap
$4.00
Share price
-0.67%
Change (1 day)
-31.90%
Change (1 year)

Fulcrum Therapeutics (FULC) - Cash on Hand

Cash on Hand as of June 2024 : S$0.36 Billion

According to Fulcrum Therapeutics's latest financial reports the company has S$0.36 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Fulcrum Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.31 B14.68%
2022-12-31S$0.27 B-7.76%
2021-12-31S$0.29 B97.44%
2020-12-31S$0.14 B14.57%
2019-12-31S$0.13 B31.11%
2018-12-31S$99.45 M18169.37%
2017-12-31S$0.54 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.38 B 4.61%๐Ÿ‡บ๐Ÿ‡ธ USA